Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
938 11 |
Ultima descărcare din IBN: 2024-01-19 09:48 |
SM ISO690:2012 AGACHI, Svetlana, GROPPA, Liliana, ABABII, Ion, CEPOI-BULGAC, Daniela, ROTARU, Larisa. Evoluţia sindromului raynaud la pacienţii cu sclerodermie sistemică în dependenţă de tratamentul aplicat
. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2009, nr. 3(10), pp. 80-83. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 3(10) / 2009 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 80-83 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Evolution of the raynaud’s syndrome in patients with systemic scleroderma dependent on the applied therapy
The study aimed at assessing 45 patients with systemic scleroderma (SS) distributed into
3 groups with various therapy regimens for Raynaud’s syndrome. Treatment outcomes were
evaluated after 6 months analyzing duration and frequency of attacks, development of
complications and comparative assessment of the quality of life of the studied patients. The
patients of the group that administered Pentoxyphilin plus Eprosartan showed superior results. |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Agachi, S.A.</dc:creator> <dc:creator>Groppa, L.G.</dc:creator> <dc:creator>Ababii, I.I.</dc:creator> <dc:creator>Cepoi-Bulgac, D.</dc:creator> <dc:creator>Rotaru, L.A.</dc:creator> <dc:date>2009-10-01</dc:date> <dc:description xml:lang='en'>Evolution of the raynaud’s syndrome in patients with systemic scleroderma dependent on the applied therapy The study aimed at assessing 45 patients with systemic scleroderma (SS) distributed into 3 groups with various therapy regimens for Raynaud’s syndrome. Treatment outcomes were evaluated after 6 months analyzing duration and frequency of attacks, development of complications and comparative assessment of the quality of life of the studied patients. The patients of the group that administered Pentoxyphilin plus Eprosartan showed superior results.</dc:description> <dc:description xml:lang='ro'>Studiul a fost axat pe studierea a 45 pacienţi cu sclerodermie sistemică (SS) repartizaţi în 3 grupe cu diferse scheme de tratament a sindromului Raynaud. Rezultatele tratamentului a fost apreciate peste 6 luni analizînd durata, frecvenţa acceselor, dezvoltarea complicaţiilor şi analiza comparativă a calităţii vieţii pacienţilor. Rezultate mai supperioare au demonstrat pacienţii din grupul ce a administrat Pentoxifilina în asociere cu Eprosartanul.</dc:description> <dc:source>Analele Ştiinţifice ale USMF „N. Testemiţanu” 10 (3) 80-83</dc:source> <dc:title>Evoluţia sindromului raynaud la pacienţii cu sclerodermie sistemică în dependenţă de tratamentul aplicat </dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>